Acta Pharmaceutica Sinica B
|
2026, 16(3): 1773-1778
• Letters to the editor •
Multi-omics-based identification of METTL11B as a novel biomarker in esophageal squamous cell carcinoma
Full
Wenke Jin1,2,3, Hongyao Li1, Yanmei Chen1, Wei Wang4,5, Rui Liu3, Ning Li2, Yong Yuan1
Affiliations
1 Department of Thoracic Surgery, Med+X Center for Informatics, West China Hospital, Sichuan University, Chengdu 610041, China;
2 School of Traditional Chinese Materia Medica, Key Laboratory of Innovative Traditional Chinese Medicine for Major Chronic Diseases of Liaoning Province, Key Laboratory for TCM Material Basis Study and Innovative Drug Development of Shenyang City, Shenyang Pharmaceutical University, Shenyang 110016, China;
3 State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Chinese Academy of Medical Sciences Research Unit of Oral Carcinogenesis and Management, Department of Oral Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China;
4 Department of Thoracic Surgery, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Shenyang 110042, China;
5 Department of Thoracic Surgery, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang 110042, China
doi: 10.1016/j.apsb.2026.01.025
Outline
Esophageal squamous cell carcinoma
/
Molecular profile
/
Biomarkers
/
Regulatory network
/
Drug target
/
Precision medicine
Wenke Jin, Hongyao Li, Yanmei Chen, Wei Wang, Rui Liu, Ning Li, Yong Yuan.
Multi-omics-based identification of METTL11B as a novel biomarker in esophageal squamous cell carcinoma[J].
Acta Pharmaceutica Sinica B,
2026
, 16
(3)
: 1773
-1778
.
DOI: 10.1016/j.apsb.2026.01.025
Year 2026 volume 16 Issue 3
PDF
5
3
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.apsb.2026.01.025
- Receive Date:2025-08-12
- Online Date:2026-09-17